Ligation Devices Market Size, Share & Trends Analysis Report By Product (Appliers, Accessories), By Application (Gynecology, Cardiothoracic), By Procedure Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
Human Embryonic Stem Cells Market Growth & Trends
The global human embryonic stem cells market size is expected to reach USD 4.00 billion by 2030, registering to grow at a CAGR of 10.44% from 2025 to 2030 according to a new report by Grand View Research, Inc. Application of hESCs as a promising donor source for cellular transplantation therapies is anticipated to bolster progress through to 2025. hESCs technology tends to be useful for tissue engineering in humans due to high histocompatibility between host and graft.
Maintenance of developmental potential for contribution of derivatives of all three germ layers is an important feature of these cells. This ability remains consistent even after clonal derivation or prolonged undifferentiated proliferation, thus pronouncing its accelerated uptake.
In addition, these are capable in expressing high level of alkaline phosphatase, key transcription factors, and telomerase. These factors are found to be of great importance in the maintenance of the inner cellular mass pluripotency.
Furthermore, hESCs can be easily differentiated into defined neurons, neural lineages, oligodendrocytes, and astrocytes. Aforementioned characteristic makes it useful in studying the sequence of events that take place during early neurodevelopment.
However, use of stem cells derived from viable embryos is fraught with ethical issues, prompting scientists to explore other methods to generate ESCs. The other methods include derivation of embryonic germ cells, stem cells from dead embryos, and other techniques.
Human Embryonic Stem Cells Market Report Highlights
- Regenerative medicines dominated the market with a share of 54.18% in 2024. Regenerative medicines offer significant advancements in treating several diseases. Moreover, pluripotent cells originating from human embryos have been central to biomedical research.
- The stem cell biology research segment will witness the highest CAGR over the forecast period. Several biopharmaceutical companies have explored the potency of stem cell biology in the past.
- North America human embryonic stem cells dominated the market in 2024 owing to robust research infrastructure institutions and facilities. The rise in chronic diseases and genetic disorders has created a huge demand for gene therapies.
- Asia Pacific human embryonic stem cell market is anticipated to witness significant growth in the forecast period.
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1. Segment Definitions
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Procedure Type
- 1.1.4. End Use
- 1.1.5. Estimates and forecasts timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Procedure type outlook
- 2.2.4. End use outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
- Chapter 3. Ligation Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing number of digestive diseases
- 3.2.1.2. Technological advancement
- 3.2.1.3. Increasing number of minimally invasive procedures
- 3.2.1.4. Rising healthcare spending
- 3.2.1.5. Increasing use of ligation devices in open surgery
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of surgeries and lack of reimbursement
- 3.2.2.2. Post-surgical complications
- 3.3. Ligation Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- Chapter 4. Ligation Devices Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Ligation Devices Market: Product Movement Analysis
- 4.3. Ligation Devices Market by Product Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Appliers
- 4.5.1. Appliers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.2. Disposable
- 4.5.2.1 Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Reusable
- 4.5.3.1 Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6. Accessories
- 4.6.1. Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.2. Clips
- 4.6.2.1 Clips Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.6.3. Clips Removers
- 4.6.3.1 Clips Removers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 5. Ligation Devices Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Ligation Devices Market: Application Movement Analysis
- 5.3. Ligation Devices Market by Application Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Gastrointestinal and Abdominal Surgery
- 5.5.1. Gastrointestinal and Abdominal Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.6. Gynecological Surgery
- 5.6.1. Gynecological Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.7. Cardiothoracic Surgery
- 5.7.1. Cardiothoracic Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.8. Urological Surgery
- 5.8.1. Urological Surgery Neurovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.9. Other
- 5.9.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 6. Ligation Devices Market: Procedure Type Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Ligation Devices Market: Procedure Type Movement Analysis
- 6.3. Ligation Devices Market by Procedure Type Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. MIS
- 6.5.1. MIS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6. Open Surgery
- 6.6.1. Open Surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 7. Ligation Devices Market: End Use Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Ligation Devices Market: End Use Movement Analysis
- 7.3. Ligation Devices Market by End Use Outlook (USD Million)
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. Hospitals
- 7.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6. Ambulatory Surgical Centers
- 7.6.1. Ambulatory Surgical Centers Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- Chapter 8. Ligation Devices Market: Regional Estimates & Trend Analysis
- 8.1. Regional Market Share Analysis, 2024 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 8.5. North America
- 8.5.1. U.S.
- 8.5.1.1. Key country dynamics
- 8.5.1.2. Regulatory framework/ reimbursement structure
- 8.5.1.3. Competitive scenario
- 8.5.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
- 8.5.2. Canada
- 8.5.2.1. Key country dynamics
- 8.5.2.2. Regulatory framework/ reimbursement structure
- 8.5.2.3. Competitive scenario
- 8.5.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
- 8.5.3. Mexico
- 8.5.3.1. Key country dynamics
- 8.5.3.2. Regulatory framework/ reimbursement structure
- 8.5.3.3. Competitive scenario
- 8.5.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6. Europe
- 8.6.1. UK
- 8.6.1.1. Key country dynamics
- 8.6.1.2. Regulatory framework/ reimbursement structure
- 8.6.1.3. Competitive scenario
- 8.6.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.2. Germany
- 8.6.2.1. Key country dynamics
- 8.6.2.2. Regulatory framework/ reimbursement structure
- 8.6.2.3. Competitive scenario
- 8.6.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.3. France
- 8.6.3.1. Key country dynamics
- 8.6.3.2. Regulatory framework/ reimbursement structure
- 8.6.3.3. Competitive scenario
- 8.6.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.4. Italy
- 8.6.4.1. Key country dynamics
- 8.6.4.2. Regulatory framework/ reimbursement structure
- 8.6.4.3. Competitive scenario
- 8.6.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.5. Spain
- 8.6.5.1. Key country dynamics
- 8.6.5.2. Regulatory framework/ reimbursement structure
- 8.6.5.3. Competitive scenario
- 8.6.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.6. Norway
- 8.6.6.1. Key country dynamics
- 8.6.6.2. Regulatory framework/ reimbursement structure
- 8.6.6.3. Competitive scenario
- 8.6.6.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.7. Sweden
- 8.6.7.1. Key country dynamics
- 8.6.7.2. Regulatory framework/ reimbursement structure
- 8.6.7.3. Competitive scenario
- 8.6.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
- 8.6.8. Denmark
- 8.6.8.1. Key country dynamics
- 8.6.8.2. Regulatory framework/ reimbursement structure
- 8.6.8.3. Competitive scenario
- 8.6.8.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7. Asia Pacific
- 8.7.1. Japan
- 8.7.1.1. Key country dynamics
- 8.7.1.2. Regulatory framework/ reimbursement structure
- 8.7.1.3. Competitive scenario
- 8.7.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.2. China
- 8.7.2.1. Key country dynamics
- 8.7.2.2. Regulatory framework/ reimbursement structure
- 8.7.2.3. Competitive scenario
- 8.7.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.3. India
- 8.7.3.1. Key country dynamics
- 8.7.3.2. Regulatory framework/ reimbursement structure
- 8.7.3.3. Competitive scenario
- 8.7.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.4. Australia
- 8.7.4.1. Key country dynamics
- 8.7.4.2. Regulatory framework/ reimbursement structure
- 8.7.4.3. Competitive scenario
- 8.7.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.5. South Korea
- 8.7.5.1. Key country dynamics
- 8.7.5.2. Regulatory framework/ reimbursement structure
- 8.7.5.3. Competitive scenario
- 8.7.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
- 8.7.6. Thailand
- 8.7.6.1. Key country dynamics
- 8.7.6.2. Regulatory framework/ reimbursement structure
- 8.7.6.3. Competitive scenario
- 8.7.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
- 8.8. Latin America
- 8.8.1. Brazil
- 8.8.1.1. Key country dynamics
- 8.8.1.2. Regulatory framework/ reimbursement structure
- 8.8.1.3. Competitive scenario
- 8.8.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
- 8.8.2. Argentina
- 8.8.2.1. Key country dynamics
- 8.8.2.2. Regulatory framework/ reimbursement structure
- 8.8.2.3. Competitive scenario
- 8.8.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
- 8.9. Middle East & Africa
- 8.9.1. South Africa
- 8.9.1.1. Key country dynamics
- 8.9.1.2. Regulatory framework/ reimbursement structure
- 8.9.1.3. Competitive scenario
- 8.9.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
- 8.9.2. Saudi Arabia
- 8.9.2.1. Key country dynamics
- 8.9.2.2. Regulatory framework/ reimbursement structure
- 8.9.2.3. Competitive scenario
- 8.9.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
- 8.9.3. UAE
- 8.9.3.1. Key country dynamics
- 8.9.3.2. Regulatory framework/ reimbursement structure
- 8.9.3.3. Competitive scenario
- 8.9.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
- 8.9.4. Kuwait
- 8.9.4.1. Key country dynamics
- 8.9.4.2. Regulatory framework/ reimbursement structure
- 8.9.4.3. Competitive scenario
- 8.9.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)
- Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.2.1. Innovators
- 9.2. Vendor Landscape
- 9.2.1. List of key distributors and channel partners
- 9.2.2. Key customers
- 9.2.3. Key company market share analysis, 2024
- 9.2.4. Medtronic
- 9.2.4.1. Company overview
- 9.2.4.2. Financial performance
- 9.2.4.3. Product benchmarking
- 9.2.4.4. Strategic initiatives
- 9.2.5. Johnson & Johnson Services, Inc.
- 9.2.5.1. Company overview
- 9.2.5.2. Financial performance
- 9.2.5.3. Product benchmarking
- 9.2.5.4. Strategic initiatives
- 9.2.6. The Cooper Companies, Inc.
- 9.2.6.1. Company overview
- 9.2.6.2. Financial performance
- 9.2.6.3. Product benchmarking
- 9.2.6.4. Strategic initiatives
- 9.2.7. CONMED Corporation.
- 9.2.7.1. Company overview
- 9.2.7.2. Financial performance
- 9.2.7.3. Product benchmarking
- 9.2.7.4. Strategic initiatives
- 9.2.8. B. Braun SE
- 9.2.8.1. Company overview
- 9.2.8.2. Financial performance
- 9.2.8.3. Product benchmarking
- 9.2.8.4. Strategic initiatives
- 9.2.9. Teleflex Incorporated.
- 9.2.9.1. Company overview
- 9.2.9.2. Financial performance
- 9.2.9.3. Product benchmarking
- 9.2.9.4. Strategic initiatives
- 9.2.10. Olympus Corporation
- 9.2.10.1. Company overview
- 9.2.10.2. Financial performance
- 9.2.10.3. Product benchmarking
- 9.2.10.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook